<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE LIFECORE BIOMEDICAL, INC. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED JUNE 30, 1996 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <PERIOD-TYPE> 12-MOS <FISCAL-YEAR-END> JUN-30-1996 <PERIOD-START> JUL-01-1995 <PERIOD-END> JUN-30-1996 <CASH> 3,264,000 <SECURITIES> 35,084,000 <RECEIVABLES> 2,612,000 <ALLOWANCES> 286,000 <INVENTORY> 7,968,000 <CURRENT-ASSETS> 27,291,000 <PP&E> 13,670,000 <DEPRECIATION> 5,009,000 <TOTAL-ASSETS> 64,429,000 <CURRENT-LIABILITIES> 5,084,000 <BONDS> 7,193,000 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 121,000 <OTHER-SE> 52,031,000 <TOTAL-LIABILITY-AND-EQUITY> 64,429,000 <SALES> 14,063,000 <TOTAL-REVENUES> 14,063,000 <CGS> 9,173,000 <TOTAL-COSTS> 9,162,000 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 814,000 <INCOME-PRETAX> (4,000,000) <INCOME-TAX> 0 <INCOME-CONTINUING> (4,000,000) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (4,000,000) <EPS-PRIMARY> (.40) <EPS-DILUTED> (.40)